<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>2024 Archivi - Adres</title>
	<atom:link href="https://adreshe.com/category/articoli/2024/feed/" rel="self" type="application/rss+xml" />
	<link>https://adreshe.com/category/articoli/2024/</link>
	<description>Health Economics &#38; Outcomes Research</description>
	<lastBuildDate>Mon, 03 Mar 2025 13:47:26 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://adreshe.com/wp-content/uploads/2024/06/cropped-Logo-Ad-32x32.png</url>
	<title>2024 Archivi - Adres</title>
	<link>https://adreshe.com/category/articoli/2024/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Implantation of Reveal LINQ in Different Italian Scenarios: How to Further Improve?</title>
		<link>https://adreshe.com/implantation-of-reveal-linq-in-different-italian-scenarios-how-to-further-improve/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 09 Sep 2024 12:40:10 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5007</guid>

					<description><![CDATA[<p>Senatore G., Di Lorenzo E., Zaniolo O., Liuzzi G. – Farmeconomia. Health economics and therapeutic pathways 2024; 25(1): 19-29</p>
<p>L'articolo <a href="https://adreshe.com/implantation-of-reveal-linq-in-different-italian-scenarios-how-to-further-improve/">Implantation of Reveal LINQ in Different Italian Scenarios: How to Further Improve?</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Senatore G., Di Lorenzo E., Zaniolo O., Liuzzi G. – Farmeconomia. Health economics and therapeutic pathways 2024; 25(1): 19-29</p>



<p></p>
<p>L'articolo <a href="https://adreshe.com/implantation-of-reveal-linq-in-different-italian-scenarios-how-to-further-improve/">Implantation of Reveal LINQ in Different Italian Scenarios: How to Further Improve?</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Optimizing Treatment of Schizophrenia: Clinical and Economical Potential for Patient Switching to Long‑Acting Injectables</title>
		<link>https://adreshe.com/optimizing-treatment-of-schizophrenia-clinical-and-economical-potential-for-patient-switching-to-long%e2%80%91acting-injectables/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 09 Sep 2024 12:36:39 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5003</guid>

					<description><![CDATA[<p>Zaniolo O., Maffezzoli S., Povero M., Pradelli L. – Farmeconomia. Health economics and therapeutic pathways 2024; 25(1): 9-17</p>
<p>L'articolo <a href="https://adreshe.com/optimizing-treatment-of-schizophrenia-clinical-and-economical-potential-for-patient-switching-to-long%e2%80%91acting-injectables/">Optimizing Treatment of Schizophrenia: Clinical and Economical Potential for Patient Switching to Long‑Acting Injectables</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Zaniolo O., Maffezzoli S., Povero M., Pradelli L. – Farmeconomia. Health economics and therapeutic pathways 2024; 25(1): 9-17</p>



<p></p>
<p>L'articolo <a href="https://adreshe.com/optimizing-treatment-of-schizophrenia-clinical-and-economical-potential-for-patient-switching-to-long%e2%80%91acting-injectables/">Optimizing Treatment of Schizophrenia: Clinical and Economical Potential for Patient Switching to Long‑Acting Injectables</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis</title>
		<link>https://adreshe.com/cost-per-responder-analysis-of-filgotinib-in-patients-suffering-from-ulcerative-colitis/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 09 Sep 2024 12:30:14 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5009</guid>

					<description><![CDATA[<p>Povero M., Castello L., Pradelli L., Visentin E. – Farmeconomia. Health economics and therapeutic pathways 2024; 25(1): 1-7</p>
<p>L'articolo <a href="https://adreshe.com/cost-per-responder-analysis-of-filgotinib-in-patients-suffering-from-ulcerative-colitis/">Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Povero M., Castello L., Pradelli L., Visentin E. – Farmeconomia. Health economics and therapeutic pathways 2024; 25(1): 1-7</p>



<p></p>
<p>L'articolo <a href="https://adreshe.com/cost-per-responder-analysis-of-filgotinib-in-patients-suffering-from-ulcerative-colitis/">Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study.</title>
		<link>https://adreshe.com/tissue-and-liquid-biopsy-based-ngs-profiling-in-advanced-non-small-cell-lung-cancer-in-a-real-world-setting-the-imminent-study/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 04 Feb 2024 12:26:38 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5354</guid>

					<description><![CDATA[<p>Sposito M, Belluomini L, Nocini R, et al. Front Oncol 2024; 14: 1436588.</p>
<p>L'articolo <a href="https://adreshe.com/tissue-and-liquid-biopsy-based-ngs-profiling-in-advanced-non-small-cell-lung-cancer-in-a-real-world-setting-the-imminent-study/">Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Sposito M, Belluomini L, Nocini R, et al. <em>Front Oncol</em> 2024; 14: 1436588.</p>
<p>L'articolo <a href="https://adreshe.com/tissue-and-liquid-biopsy-based-ngs-profiling-in-advanced-non-small-cell-lung-cancer-in-a-real-world-setting-the-imminent-study/">Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Sub-Optimal Compliance to Long-Term Inhalation Strategies and Poorer Health Care Outcomes Associated with Extended Tattoos in Adolescents with Mild-to-Moderate  Bronchial Asthma.</title>
		<link>https://adreshe.com/sub-optimal-compliance-to-long-term-inhalation-strategies-and-poorer-health-care-outcomes-associated-with-extended-tattoos-in-adolescents-with-mild-to-moderate-bronchial-asthma/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 04 Feb 2024 12:24:49 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5352</guid>

					<description><![CDATA[<p>Dal Negro RW, Turco P, Povero M. Child Basel Switz 2024; 11</p>
<p>L'articolo <a href="https://adreshe.com/sub-optimal-compliance-to-long-term-inhalation-strategies-and-poorer-health-care-outcomes-associated-with-extended-tattoos-in-adolescents-with-mild-to-moderate-bronchial-asthma/">Sub-Optimal Compliance to Long-Term Inhalation Strategies and Poorer Health Care Outcomes Associated with Extended Tattoos in Adolescents with Mild-to-Moderate  Bronchial Asthma.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Dal Negro RW, Turco P, Povero M. <em>Child Basel Switz</em> 2024; 11</p>
<p>L'articolo <a href="https://adreshe.com/sub-optimal-compliance-to-long-term-inhalation-strategies-and-poorer-health-care-outcomes-associated-with-extended-tattoos-in-adolescents-with-mild-to-moderate-bronchial-asthma/">Sub-Optimal Compliance to Long-Term Inhalation Strategies and Poorer Health Care Outcomes Associated with Extended Tattoos in Adolescents with Mild-to-Moderate  Bronchial Asthma.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Single-Breath Simultaneous Measurement of DL(NO) and DL(CO) as Predictor of the Emphysema Component in COPD &#8211; A Retrospective Observational Study.</title>
		<link>https://adreshe.com/single-breath-simultaneous-measurement-of-dlno-and-dlco-as-predictor-of-the-emphysema-component-in-copd-a-retrospective-observational-study/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 04 Feb 2024 12:23:42 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5350</guid>

					<description><![CDATA[<p>Dal Negro RW, Turco P, Povero M. Int J Chron Obstruct Pulmon Dis 2024; 19: 2123-33.</p>
<p>L'articolo <a href="https://adreshe.com/single-breath-simultaneous-measurement-of-dlno-and-dlco-as-predictor-of-the-emphysema-component-in-copd-a-retrospective-observational-study/">Single-Breath Simultaneous Measurement of DL(NO) and DL(CO) as Predictor of the Emphysema Component in COPD &#8211; A Retrospective Observational Study.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Dal Negro RW, Turco P, Povero M. <em>Int J Chron Obstruct Pulmon Dis</em> 2024; 19: 2123-33. </p>
<p>L'articolo <a href="https://adreshe.com/single-breath-simultaneous-measurement-of-dlno-and-dlco-as-predictor-of-the-emphysema-component-in-copd-a-retrospective-observational-study/">Single-Breath Simultaneous Measurement of DL(NO) and DL(CO) as Predictor of the Emphysema Component in COPD &#8211; A Retrospective Observational Study.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Multiple myeloma in Italy: an epidemiological model by treatment line and refractoriness status.</title>
		<link>https://adreshe.com/multiple-myeloma-in-italy-an-epidemiological-model-by-treatment-line-and-refractoriness-status/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 04 Feb 2024 11:50:33 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5342</guid>

					<description><![CDATA[<p>Mina R, Mangiacavalli S, Rossini B, et al. Clin Lymphoma Myeloma Leuk 2024; 0.</p>
<p>L'articolo <a href="https://adreshe.com/multiple-myeloma-in-italy-an-epidemiological-model-by-treatment-line-and-refractoriness-status/">Multiple myeloma in Italy: an epidemiological model by treatment line and refractoriness status.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Mina R, Mangiacavalli S, Rossini B, et al. <em>Clin Lymphoma Myeloma Leuk</em> 2024; 0. </p>
<p>L'articolo <a href="https://adreshe.com/multiple-myeloma-in-italy-an-epidemiological-model-by-treatment-line-and-refractoriness-status/">Multiple myeloma in Italy: an epidemiological model by treatment line and refractoriness status.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>mRNA vaccines protect from the lung microvasculature injury and the capillary blood volume loss occurring in SARS-CoV-2 paucisymptomatic infections.</title>
		<link>https://adreshe.com/mrna-vaccines-protect-from-the-lung-microvasculature-injury-and-the-capillary-blood-volume-loss-occurring-in-sars-cov-2-paucisymptomatic-infections/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 04 Feb 2024 11:49:37 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5340</guid>

					<description><![CDATA[<p>Dal Negro RW, Turco P, Povero M. Multidiscip Respir Med 2024; 19.</p>
<p>L'articolo <a href="https://adreshe.com/mrna-vaccines-protect-from-the-lung-microvasculature-injury-and-the-capillary-blood-volume-loss-occurring-in-sars-cov-2-paucisymptomatic-infections/">mRNA vaccines protect from the lung microvasculature injury and the capillary blood volume loss occurring in SARS-CoV-2 paucisymptomatic infections.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Dal Negro RW, Turco P, Povero M. <em>Multidiscip Respir Med</em> 2024; 19.</p>
<p>L'articolo <a href="https://adreshe.com/mrna-vaccines-protect-from-the-lung-microvasculature-injury-and-the-capillary-blood-volume-loss-occurring-in-sars-cov-2-paucisymptomatic-infections/">mRNA vaccines protect from the lung microvasculature injury and the capillary blood volume loss occurring in SARS-CoV-2 paucisymptomatic infections.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and meta-analysis.</title>
		<link>https://adreshe.com/mortality-and-morbidity-after-total-intravenous-anaesthesia-versus-inhalational-anaesthesia-a-systematic-review-and-meta-analysis/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 04 Feb 2024 11:48:41 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5338</guid>

					<description><![CDATA[<p>Kampman JM, Hermanides J, Hollmann MW, et al. eClinicalMedicine 2024; 72.</p>
<p>L'articolo <a href="https://adreshe.com/mortality-and-morbidity-after-total-intravenous-anaesthesia-versus-inhalational-anaesthesia-a-systematic-review-and-meta-analysis/">Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and meta-analysis.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Kampman JM, Hermanides J, Hollmann MW, et al. <em>eClinicalMedicine</em> 2024; 72. </p>
<p>L'articolo <a href="https://adreshe.com/mortality-and-morbidity-after-total-intravenous-anaesthesia-versus-inhalational-anaesthesia-a-systematic-review-and-meta-analysis/">Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and meta-analysis.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Fish oil lipid emulsion compared with soybean oil lipid emulsion in pediatric patients with parenteral nutrition-associated cholestasis: A cost-effectiveness  study.</title>
		<link>https://adreshe.com/fish-oil-lipid-emulsion-compared-with-soybean-oil-lipid-emulsion-in-pediatric-patients-with-parenteral-nutrition-associated-cholestasis-a-cost-effectiveness-study/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 04 Feb 2024 11:46:37 +0000</pubDate>
				<category><![CDATA[2024]]></category>
		<category><![CDATA[ARTICOLI]]></category>
		<guid isPermaLink="false">https://adreshe.com/?p=5336</guid>

					<description><![CDATA[<p>Povero M, Gura KM, Premkumar MH, et al. JPEN J Parenter Enteral Nutr 2024.</p>
<p>L'articolo <a href="https://adreshe.com/fish-oil-lipid-emulsion-compared-with-soybean-oil-lipid-emulsion-in-pediatric-patients-with-parenteral-nutrition-associated-cholestasis-a-cost-effectiveness-study/">Fish oil lipid emulsion compared with soybean oil lipid emulsion in pediatric patients with parenteral nutrition-associated cholestasis: A cost-effectiveness  study.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Povero M, Gura KM, Premkumar MH, et al. <em>JPEN J Parenter Enteral Nutr</em> 2024.</p>
<p>L'articolo <a href="https://adreshe.com/fish-oil-lipid-emulsion-compared-with-soybean-oil-lipid-emulsion-in-pediatric-patients-with-parenteral-nutrition-associated-cholestasis-a-cost-effectiveness-study/">Fish oil lipid emulsion compared with soybean oil lipid emulsion in pediatric patients with parenteral nutrition-associated cholestasis: A cost-effectiveness  study.</a> proviene da <a href="https://adreshe.com">Adres</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
